Looks like as well that while they agree that it was the same idea, they seem to disagree about who stole the IP from whom. They just filed a counterclaim. Now the courts just need to establish who had it first:
Overall - I just hope that they find a way to sort the whole thing without a long court battle. Though its not David against Goliath, but ResMed is larger than F&P and they might have as well some benefits by sitting closer the the US justice system.
However it goes - the clear winner will be a number of lawyers ... lets hope its not the shareholders to loose.
----
"Prediction is very difficult, especially about the future" (Niels Bohr)
Looks like as well that while they agree that it was the same idea, they seem to disagree about who stole the IP from whom. They just filed a counterclaim. Now the courts just need to establish who had it first:
Overall - I just hope that they find a way to sort the whole thing without a long court battle. Though its not David against Goliath, but ResMed is larger than F&P and they might have as well some benefits by sitting closer the the US justice system.
However it goes - the clear winner will be a number of lawyers ... lets hope its not the shareholders to loose.
It would be interesting to see whether FPH have included IP Insurance as part of their risk management programme. If so, then the effects of this could be negligible. Most likely there will be a settlement one way or another and both parties will move on.
It would be interesting to see whether FPH have included IP Insurance as part of their risk management programme. If so, then the effects of this could be negligible. Most likely there will be a settlement one way or another and both parties will move on.
A good question to ask on Tuesday (I can't be there unfortunately).
Bookmarks